Comparing the current results to its competitors, Sunshine Biopharma Inc reported Revenue decrease in the 2 quarter 2026 year on year by -1.56 %, despite the revenue increase by the most of its competitors of 1.96 %, recorded in the same quarter.
Sunshine Biopharma Inc 's Comment on Competition and Industry Peers
The company operates in the anticancer drug development sector, competing with both large publicly and privately held pharmaceutical companies, including Merck, Amgen, Roche, Pfizer, Bristol-Myers Squibb, and Novartis. These companies have ongoing anticancer drug development programs, with some products potentially competing directly with the company's offerings. The company also faces competition from smaller firms developing cancer therapies.
December 4, 2023
Sunshine Biopharma Expands Presence in New York City and Shows Impressive Revenue Growth In a recent announcement, Sunshine Biopharma, Inc. (NASDAQ: SBFM), a renowned pharmaceutical company specializing in life-saving medicines, revealed that it has relocated its headquarters to New York City. The company s new office is situated at 1177 Avenue of the Americas, 5th Floor, New York, NY 10036, while its satellite office will continue to operate in Montreal, Canada. This strategic move aims to position Sunshine Biopharma in the heart of the global pharmaceutical industry and enhance its growth prospects. With a focus on therapeutic areas such as oncology and antivirals, Sunshine Biopharma has been at th...
Journey Medical Corporation is a pharmaceutical and medical device company that specializes in developing and commercializing innovative products for dermatology and aesthetics. Their business model revolves around conducting research and development to create new products, acquiring the necessary regulatory approvals, and partnering with healthcare professionals to effectively distribute and market these products. By focusing on dermatology and aesthetics, Journey Medical Corporation aims to address unmet medical needs and provide cutting-edge solutions to improve patient outcomes in these fields.
Moleculin Biotech Inc is a biopharmaceutical company that develops innovative cancer therapies by targeting key enzymes and signaling pathways involved in the progression of tumors. Their business model revolves around conducting preclinical and clinical trials to advance their drug candidates, with a focus on maximizing therapeutic impact and commercial potential.
Mineralys Therapeutics Inc is a biotechnology company that follows the business model of developing and commercializing novel therapeutics for various diseases. They focus on discovering and advancing small molecule drugs based on innovative research approaches. Their business model is centered around conducting preclinical and clinical trials, obtaining regulatory approvals, and ultimately bringing their therapeutic products to market for improved patient outcomes.
MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of inhaled therapeutic solutions for patients with diseases such as diabetes and pulmonary arterial hypertension. The company's business model revolves around conducting research and development to create innovative inhalation therapies and gaining regulatory approvals for these treatments. They then market and distribute their products, either directly or through partnerships, to healthcare providers and patients worldwide.
Medicinova Inc operates under a biopharmaceutical business model, primarily focused on the development and commercialization of innovative therapeutics. They strive to identify promising drug candidates with the potential to address unmet medical needs and advance them through clinical trials. By leveraging their research capabilities, strategic partnerships, and licensing opportunities, Medicinova Inc aims to bring these novel treatments to market and improve patient outcomes.
Sources:
Sunshine Biopharma Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sunshine Biopharma Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
